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ABSTRACT 
Objective: A simple, direct and accurate spectrophotometric method has been developed for the determination of rosuvastatin (RSV) in pure and 
pharmaceutical formulations by complex formation with bromocresol green (BCG).  
Methods: The method involves the formation of a yellow ion-pair complex between rosuvastatin (RSV) and bromocresol green (BCG) reagent in 
chloroform. 
Results: The formed complex was measured at λmax 416 nm against the reagent blank prepared in the same manner. Variables were studied in 
order to optimize the reaction conditions. Beer’s law was obeyed in the concentration range of 0.482-24.077 μg/ml with good correlation coefficient 
(R2= 0.9996). The relative standard deviation did not exceed 2.8%. The limit of detection (LOD) and the limit of quantification (LOQ) were 0.045 and 
0.13 μg/ml, respectively. No interferences were caused by excipients, aspirin (ASP) and fenofibrate (FEN), but Ezetimibe (EZE), clopidogrel (CP), 
telmisartan (TEL), glimepiride (GLM) and diltiazem (DIL), interfere. 
Conclusion: The developed method is applicable for the determination of rosuvastatin in pure and different dosage forms with an average recovery 
of 96.0 to 105.0% and the results are in good agreement with those obtained by the RP-HPLC reference methods.  
Keywords: Direct spectrophotometric method, Rosuvastatin, Bromocresol green, Ion-pair complex.  
 
INTRODUCTION 
Rosuvastatin calcium (C22H27FN3O6S)2Ca, mol. mass 1001.14 g, is a 
synthetic lipid lowering agent which belongs to the drug class 
known as statins. It is widely used to treat hypercholesterolemia and 
prevent cardiovascular diseases. It is the calcium salt of (E)-7-[4-(4-
fluorophenyl)-6-isopropyl-2-[methyl (methyl sulfonyl) amino] 
pyrimidin-5-yl] (3R, 5S)-3,5-di hydroxyhept-6-enoic acid, while 
rosuvastatin (RSV) is C22H28FN3O6S and its mol. mass is 481.539 g, 
see scheme 1. Rosuvastatin calcium is a white amorphous powder 
slightly soluble in water, freely soluble in methanol, ethanol, 
chloroform, DMSO and DMF [1-4]. 
 
  
Rosuvastatin C22H28FN3O6S, RSV Rosuvastatin calcium (C22H27FN3O6S)2Ca, RSVCa 
Scheme 1: Chemical structure of rosuvastatin and rosuvastatin calcium 
 
Bromocresol green (C21H14Br4O5S), mol. mass 698.01 g, is a dye of the 
triphenylmethane family (triarylmethane dyes), see scheme 2 [5].  
 
 
Scheme 2: Chemical structure of bromocresol green 
(C21H14Br4O5S) 
Various spectrophotometric [6-40], HPLC [41-43], capillary zone 
electrophoresis [44] and electrochemical methods [45-47] have 
been reported for the determination of rosuvastatin calcium in pure 
as well as in dosage forms. Spectrophotometric methods based on 
complex formation were successfully applied for the determination 
of rosuvastatin directly or by extraction [6-13]. 
A simple, sensitive and economical spectrophotometric method is 
developed for the determination of rosuvastatin calcium RSVCa in 
pure form and its pharmaceutical formulations in acetonitrile. This 
method is based on the oxidation of rosuvastatin calcium by iodine 
and formation triiodide (I3−) complex. The formed complex was 
measured at 291 and 360 nm against the reagent blank prepared in 
the same manner. The optimum experimental parameters are 
selected. Beer’s law is valid within a concentration range of 2.408-
48.154 μg/ml. The developed method is applied for the 
determination of rosuvastatin calcium in pure and its 
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pharmaceutical formulations without any interference from 
excipients with an average recovery of 95.8 to 104.0% [6]. 
A simple and sensitive visible direct spectrophotometric method has 
been developed for the estimation of rosuvastatin calcium in bulk 
and pharmaceutical dosage forms. This method is based on the 
reaction of RSVCa with 3-methyl 1,2 benzthiazoline hydrazide 
hydrochloride reagent (MBTH) in presence of ferric chloride 
solution, to produce a green color (λmax 631 nm). Beer’s law was 
obeyed in the concentration range of 5–30 μg/ml [7].  
Simple and sensitive direct spectrophotometric methods were also 
developed for the estimation of rosuvastatin in bulk and 
pharmaceutical dosage forms. The first method is based on oxidation 
followed by complex formation of the drug with chloralinic acid (λmax 
530 nm) and the second method is based on oxidation followed by 
complex formation of the drug with potassium permanganate (λmax 
410 nm). Beer’s law was obeyed in the concentration ranges 1-3 
μg/ml and 0.25-1.25 μg/ml for two methods, respectively [8]. 
A sensitive and rapid extractive spectrophotometric method has 
been developed for the assay of rosuvastatin calcium (RSVCa) in 
pharmaceutical formulations. The method is based on the formation 
of ion-pair complex with Safranin (SFN) in phosphate buffer at pH 
7.2. The complex was extracted into chloroform then measured at 
518 nm. Beer’s law was obeyed in the concentration range of 5-25 
μg/ml. Limit of detection and Limit of quantification for rosuvastatin 
calcium were found to be 1.5 μg/ml and 2.5 μg/ml, respectively [9].  
Two simple extractive Spectrophotometric methods are 
described for the determination of rosuvastatin calcium (RSVCa) 
in pure form and in pharmaceutical formulations. These methods 
are based on the formation of ion association complexes of the 
RSV with basic dyes safranin O (Method A) and methylene blue 
(Method B) in basic buffer of pH 9.8 followed by their extraction 
in chloroform. The absorbance of the chloroform layer for each 
method was measured at its appropriate λmax against the reagent 
blank. Beer’s law was obeyed in the concentration range of 5.0–
25.0 μg/ml and 2.5–12.5 μg/ml, respectively. These methods 
have been statistically evaluated and are found to be precise and 
accurate [10]. 
Two simple and sensitive methods have been developed for the 
estimation of rosuvastatin in bulk and in pharmaceutical dosage 
forms. Method A is based on the oxidative coupling of rosuvastatin 
with MBTH in the presence of oxidant cerric ammonium sulphate, 
λmax 658 nm. Method B is based on the formation of co-ordination 
complex between rosuvastatin and cobalt thiocyanate and the blue 
colored complex formed is extracted into nitrobenzene, λmax 626 nm. 
The colored species obeyed Beer’s Law in the concentration range 2-
14 μg/ml and 50-250 μg/ml for method A and method B 
respectively. Recovery studies were carried out by the standard 
addition method. Both the proposed methods were applied for the 
determination of rosvastatin in bulk and pharmaceutical dosage 
forms [11]. 
Simple and accurate spectrophotometric methods are presented for 
the determination of five 3-hydroxy-3-methylglutaryl coenzyme-A 
(HMG-CoA) reductase inhibitors (statins), including rosuvastatin, in 
pharmaceutical preparations based on the reaction of drugs as n-
electron donors with 7,7,8,8-tetracyanoquinodimethane as π-
acceptors to give highly colored complex species which were 
extracted by suitable solvent [12]. 
Most spectrophotometric methods employ ion-pair extraction 
procedures. In this case, the ion-pair complex was extracted into an 
organic solvent, which is immiscible with water, and the 
concentration of the resulting ion pair in the organic phase is 
determined spectrophotometrically. The ion-pair extraction 
technique has some difficulties and inaccuracies due to incomplete 
extraction or the formation of emulsions between the hydrocarbon 
solvent and the basic compound-containing solution. In response to 
the problems resulting from extraction of the ion-pair complex, it is 
better to determine formed ion pair complex without extraction 
[48]. In this study, extraction-free spectrophotometric method for 
determination of RSV was developed. 
MATERIALS AND METHODS 
Instruments and apparatus 
Spectrophotometric measurements were made in Spectro Scan 80 
DV UV-VIS Spectrophotometr with 0.2 cm and 1 cm quartz cells. An 
ultrasonic processor model POWERSONIC 405 was used to sonicate 
the sample solutions. The diluter pipette model DIP-1 (Shimadzu), 
having 100 μl sample syringes and five continuously adjustable 
pipettes covering a volume range from 20 to 5000 μl (model 
PIPTMAN P, GILSON).  
Centrifuge (Centurion Scientific Ltd., Model: K2080-Manufactured in 
the United Kingdom) was used for preparation of the experimental 
solutions. SARTORIUS TE64 electronic balance was used for 
weighing the samples. 
Reagents 
Rosuvastatin calcium (98.6%) was supplied by BDR 
PHARMACEUTICALS INTERNATIONAL PVT. LTD. (INDIA), its purity 
as rosuvastatin was 94.66%. Aspirin, fenofibrate, Ezetimibe, 
clopidogrel, telmisartan, glimepiride and diltiazem were obtained as 
gift sample from ASIA, BARAKAT, BAHRI, DIAMOND and 
UNIPHARMA Co. in Syria. Bromocresol green (97%) of analytical 
grade and chloroform extra pure was from MERCK. All solvents and 
reagents were analytical grade chemicals. 
Stock standard solution of bromocresol green (1x10-3 mol/l) 
Accurately weighed 35.98 mg of BCG was dissolved in chloroform 
into the volumetric flask (50 ml) and diluted up to mark with 
chloroform. 
Stock standard solution of rosuvastatin (1x10-4 mol/l) 
This solution was prepared by dissolving 25.38 mg of (RSVCa) in 
chloroform then diluting to 50 ml with chloroform, 1x10-3 mol/l of 
RSV (a), then diluting 5.000 ml from this solution to 50 ml with 
chloroform, 1x10-4 mol/l of RSV (b). 
Working standard solutions of rosuvastatin 
The stock solution was further diluted daily just before the use to 
obtain working solutions of RSV in the concentrations: 1, 2, 4, 6, 8, 
10, 20, 30, 40 and 50 μM (0.482, 0.963, 1.926, 2.889, 3.852, 4.815, 
9.631, 14.446, 19.262 and 24.077 μg/ml) by transferring different 
aliquots from stock standard solution (b): 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 
2.0, 3.0, 4.0 and 5.0 ml into 10 ml volumetric flasks, then 1 ml from 
stock standard solution of BCG was added, diluted to 10 ml with 
chloroform.  
Sample preparation  
Commercial formulations (as tablet) were used for the analysis of 
rosuvastatin. The pharmaceutical formulations subjected to the 
analytical procedure were:  
(1) Rosuvastatin tablets, Balsam pharma Co., Homs–SYRIA (Mfg. 
07/2013, Exp. 07/2017), each tablet contains: 5,10,20 and 40 mg of RSV. 
(2) Rosuvastatin-ElSaad tablets, ELSaad pharma, Aleppo–SYRIA, 
(Mfg. 04/2012, Exp. 04/2016), Each tablet contains: 5,10,20 and 40 
mg of RSV. 
(3) Turbovas tablets, City pharma Co., Aleppo-SYRIA, (Mfg. 03/2012, 
Exp. 03/2016, each tablet contains: 10 and 20 mg of RSV.  
Stock solutions of pharmaceutical formulations 
Ten tablets of each studied pharmaceutical formulation were 
weighed accurately, crushed to a fine powder and mixed well. An 
amount of the powder equivalent to the tenth of the weight of one 
tablet was solved in chloroform using ultrasonic, 10 ml of 
chloroform was added, filtered over a 50 ml flask and washed by the 
same solvent, then diluted to 50 ml with chloroform.  
This solution contains the follows: 10, 20, 40 and 80 µg/ml of RSV 
for all studied pharmaceutical formulations contain 5, 10, 20 and 40 
mg/tab, respectively. 
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Working solutions of pharmaceuticals 
These solutions were prepared daily by diluting 2.00, 1.00, 0.50 and 
0.25 ml from stock solutions of pharmaceutical formulations for 
contents: 5, 10, 20 and 40 mg/tab, respectively, then adding 1 ml 
from stock standard solution of BCG and adjusting the volume up to 
10 ml with chloroform (each solution contains 2 μg/ml of RSV). 
Working standard addition solutions of pharmaceuticals 
Aliquots (2.00, 1.00, 0.50 and 0.25 ml) from stock solutions of 
pharmaceuticals for different dosage forms, respectively, were taken 
with 0.40, 0.80, 2.00 and 4.00 ml from stock standard solution (b) of 
RSV, and 1.0 ml from stock standard solution of BCG was added, then 
diluted to 10 ml with chloroform; these solutions contain 2.000 
μg/ml of RSV (from pharmaceuticals) plus 1.926, 3.852, 9.631 and 
19.262 μg/ml of standard rosuvastatin, respectively. 
Procedure 
A solution (10 ml) containing an appropriate concentration of 
rosuvastatin (or working solutions of pharmaceuticals or working 
standard addition solutions of pharmaceuticals) with an appropriate 
amount of bromocresol green in chloroform was ready for 
spectrophotometric measurement at λmax =416 nm.  
RESULTS AND DISCUSSION 
The different experimental parameters affecting the spectro 
photometric determination of rosuvastatin calcium through ion-pair 
complex formation with bromocreol green in chloroform were 
studied in order to determine the optimal conditions for the 
determination of RSV.  
Spectrophotometric results  
UV-Vis spectra of RSVCa, BCG, the formed complex BCG: RSV, ASP and 
FEN solutions (using chloroform as blank) were obtained. RSVCa, ASP 
and FEN solutions do not absorb in the range 400-600 nm. 
Bromocresol green (BCG) solutions have small absorption at 416 
nm. BCG: RSV complex solutions have maximum absorption at 416 
nm. (see fig. 1).  
 
 
Fig. 1: UV-Vis spectra in chloroform of: 1-5.0x10-5 mol/l of 
RSV; 2-1x10-4 mol/lof BCG; 3-5.0x10-5 mol/l ion-pair 
complex (5.0x10-5 mol/l of RSV with 1.0x10-4 mol/l of BCG); 
4-5.0x10-5 mol/l of FEN; 5-5.0x10-5 mol/l of ASP {blank is 
chloroform, ℓ =1 cm}  
 
The effect of time and temperature 
The effect of time and temperature on the complex formation was 
studied within the ranges 5-120 min and 15-50oC. It was found that 
the formed complex wasn't affected by time or temperature at those 
ranges.  
The effect of BCG concentration  
The effect of BCG concentration on complex formation was investigated. 
It was observed that the absorbance of the formed complex increased 
coinciding with increasing the ratio of CBCG: CRSV until the ratio (1:1), then 
stayed quasi-constant (the ratio CBCG: CRSV ≥2 was chosen).  
Composition of RSV: BCG complex 
The composition of RSV: BCG complex was determined by the molar 
ratio method and Job's method of continuous variation. 
Molar ratio method 
The stoichiometry of RSV: BCG complex was studied by molar ratio 
method according to following equation: Amax= f([RSV]/[BCG]). It 
confirmed that the binding ratio of RSV: BCG complex is equal to 
(1:1); where the concentration of BCG was constant 50 µM and the 
concentrations of RSV changed from 0 to 100 µM (fig. 2). 
 
 
Fig. 2: Molar ratio method to calculate binding ratio of RSV: 
BCG complex at λ=416 nm ([BCG]= 50 µM, blank is chloroform, 
ℓ =0.2 cm) 
 
Job’s method of continuous variation 
Continuous variation was utilized to check the composition of RSV: 
BCG complex. The absorbance of the complex was plotted against 
the mole fraction [RSV]/[RSV]+[BCG]. The plot reached maximum 
value at a mole fraction of 0.5 (fig. 3). This indicated complex 
formation (RSV: BCG) in the ratio of 1:1. 
 
 
Fig. 3: Job's method of continuous variation to calculate binding 
ratio of RSV: BCG complex at λ=416 nm ([BCG]+[RSV]=100 µM, 
blank is chloroform, ℓ =0.2 cm) 
 
The optimum conditions for spectrophotometric determination of 
rosuvastatin through ion-pair complex formation using bromocresol 
green in chloroform were shown in table 1.  
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Table 1: The optimum conditions for spectrophotometric 
determination of RSV by complex formation with BCG in 
chloroform 
Parameters Operating modes 
Temperature of solution 25±5oC 
CBCG: CRSV, M ≥2 
Solvent chloroform 
Stability (h)  24 
λmax of RSV: BCG complex 416 nm 
Molar absorptivity of RSV: BCG complex (ε ) 1.92x104 l. mol-1. cm-1 
Light path (ℓ) 0.2 and 1.0 cm 
Spectra range 200–600 nm 
Working CBCG, mol/l 1x10-4 (100 µM) 
 
Mechanism of reaction 
Anionic dyes such as BCG form ion-pair complexes with the 
positively charged nitrogen-containing molecule.  
The colour of such dyes is due to the opening of lactoid ring and 
subsequent formation of quinoid group (deprotonated). Rosuvastatin 
is protonated and forms ion-pair with the dye. Each drug-dye complex 
with two oppositely charged ions (positive on the drug and negative 
on the dye) behaves as a single unit held together by an electrostatic 
binding [47-49]. The suggested mechanism of RSV-BCG ion-pair 
complex formation is shown in Scheme 3. 
Calibration curve 
The calibration curve of RSV in pure form through complexation 
with BCG showed excellent linearity over concentration range of 1.0-
50.0 µM (0.482–24.077 μg/ml), (fig. 4 and 5).  
The spectra characteristics of the method such as the molar 
absorptivity (ε), λmax, Beer's law, regression equation {at λmax= 416 
nm (y=a. x+b); where y=absorbance, a=slope, x=concentration of 
RSV in μM or μg/ml,b=intercept} the correlation coefficient, limit of 
detection (LOD) and limit of quantification (LOQ) are summarized in 
table 1 and 2. 
 
 
Scheme 3: Mechanism of RSV: BCG complex formation 
 
Analytical results  
Spectrophotometric determination of RSV through complexation 
with BCG in chloroform within optimal conditions using the 
calibration curve was applied. The results, summarized in table 3, 
showed that the determined concentration of RSV was rectilinear 
over the range of 1.0 to 50.0 μM or 0.482 to 24.077 μg/ml with 
relative standard deviation (RSD) not more than 2.8%. The limit of 
detection (LOD) and limit of quantification (LOQ) was found to be 
0.092 and 0.28 for CRSV by μM and 0.045 and 0.13 for CRSV by μg/ml, 
respectively. The results obtained from the developed method have 
been compared with the official RP-HPLC method [42] and good 
agreement was observed between them. 
Precision and accuracy 
The precision and accuracy of proposed method was checked by 
recovery study by an addition of standard drug solution to pre-
analyzed sample solution at three different concentration levels 
(80%, 100% and 120%) within the range of linearity for RSV. The 
basic concentration level of sample solution selected for spiking of 
the RSV standard solution was 10 μg/ml. The proposed method was 
validated statistically and through recovery studies, and was 
successfully applied for the determination of RSV in pure and dosage 
forms with percent recoveries ranged from 98.4% to 100.1%.  
 
Fig. 4: Spectra of BCG (1×10-4 M) with RSV; where CRSV as the 
follows: 1-0.482; 2-0.963; 3-1.926; 4-2.889; 5-3.852; 6-4.815;7-
9.631; 8-14.446; 9-19.262; 10-24.077 µg/ml {Blank is BCG 
solution 1x10-4M in chloroform; ℓ = 1 cm}
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Fig. 5: Calibration curve for determination of RSV according to optimal conditions at λmax: 416 nm CRSV: 1.0, 2.0, 4.0, 6.0, 8.0, 10.0, 20.0, 30.0, 
40.0 and 50.0 µM (a) and 0.482, 0.963, 1.926, 2.889, 3.852, 4.815, 9.631, 14.446, 19.262 and 24.077 µg/ml (b) (Blank is BCG solution 1x10-
4 M in chloroform, ℓ = 1 cm) 
 
Table 2: The parameters established for spectrophotometric determination of RSV by complex formation with BCG in chloroform. 
Parameters Operating values 
Regression equation at λmax=416 nm for CRSV by μM:   
Slope 0.0191 
Intercept 0.0017 
Correlation coefficient (R2) 0.9996 
Regression equation at λmax=416 nm for CRSV by μg/ml:   
Slope 0.0397 
Intercept 0.0017 
Correlation coefficient (R2) 0.9996 
Beer’s Law Limit, for CRSV by μM 1.0–50.0 
Beer’s Law Limit, for CRSV by µg/ml 0.482–24.077 
RSD%  2.8 
LOD(3.3SD),  for CRSV by μM 0.092 
LOQ (10SD),  for CRSV by μM 0.28 
LOD(3.3SD),  for CRSV by µg/ml 0.045 
LOQ (10SD),  for CRSV by µg/ml 0.13 
n=5, t=2.776. 
 
Table 3: Spectrophotometric determination of RSV through complex formation with BCG within optimal conditions using calibration 
curve in chloroform 



















0.484 2.8 0.486±0.017 0.0061 0.014 0.486 0.482 
0.961 2.7 0.965±0.032 0.012 0.026 0.965 0.963 
1.930 2.6 1.947±0.063 0.023 0.051 1.947 1.926 
2.890 2.6 2.829±0.091 0.033 0.074 2.829 2.889 
3.942 2.7 3.962±0.133 0.048 0.107 3.962 3.852 
4.861 2.6 4.970±0.160 0.058 0.129 4.970 4.815 
9.630 2.4 9.352±0.279 0.100 0.224 9.352 9.631 
14.410 2.2 14.516±0.396 0.143 0.319 14.516 14.446 
19.301 2.1 19.327±0.504 0.182 0.406 19.327 19.262 
24.080 2.0 24.063±0.597 0.215 0.481 24.063 24.077 
* n=5, t= 2.776 
 
Repeatability 
The repeatability was evaluated by performing 10 repeat 
measurements for 1.926 µg/ml of RSV using the studied 
spectrophotometric method under the optimum conditions. The 
found amount of RSV ( x ±SD) was 1.947±0.051 µg/ml and the 
percentage recovery was found to be 101.1±2.6 with RSD of 0.026. 
These values indicate that the proposed method has high 
repeatability for RSV analysis. 
Application 
The developed spectrophotometric method was applied to 
determine rosuvastatin in some pharmaceutical preparations 
through complex formation by BCG in chloroform according to the 
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optimal conditions. Regression equations and correlation 
coefficients were included in table 4. Standard addition curves were 
used for the determination of rosuvastatin in different 
pharmaceutical preparations.  
The amount (m) of rosuvastatin in one tablet was calculated from 
the following relationship: m = h. m', where: m' is the amount of RSV 
in tablet calculated according to the following regression equation: 
y=a. x+b; when y=0; m'=x=b/a=intercept/slope (µg/ml), h 
conversion factor is equal to 2.5, 5, 10 and 20 for 5, 10, 20 and 40 
mg/tab of RSV. The results of quantitative analysis for RSV in some 
pharmaceutical preparations, calculated using the standard 
additions method, were summarized in Tables 5. Some 
pharmaceutical preparations of RSV contain another drug like ASP, 
FEN, EZE, CP, TEL, GLM and DIL in combined with rosuvastastin. It 
was found that neither ASP nor FEN reacts with BCG, so they don’t 
form complex with the dye, while the other drugs react with the dye.  
The proposed method was simple, direct, specific and successfully 
applied to the determination of RSV in mentioned pharmaceuticals 
without any interference from excipients, ASP and FEN. Average 
recovery ranged between 96.0 to 105.0%. The results obtained by 
this method agree well with the contents stated on the labels and 
were validated by RP-HPLC [42]. 
 
Table 4: Regression equations and correlation coefficients for determination of RSV in some pharmaceutical preparations using 
developed spectrophotometric method at λmax=416 nm 








Amount of RSV (m), 
mg/tab. 
Rosuvastatin 5 1.961 y=0.0395x+0.0774 R2=0.9992 mAT/tab.=2.5m'=4.90 
10 2.016 y=0.0399x+0.0804 R2=0.9993 mAT/tab.=5m'=10.08 
20 2.064 y=0.0398x+0.0821 R2=0.9994 mAT/tab.=10m'=20.63 
40 2.050 y=0.0392x+0.0804 R2=0.9996 mAT/tab.=20m'=40.40 
Rosuvastatin- 
Elsaad 
5 1.920 y=0.0391x+0.0751 R2=0.9993 mAT/tab.=2.5m'=4.80 
10 1.998 y=0.0397x+0.0793 R2=0.9993 mAT/tab.=5m'=9.97 
20 2.100 y=0.0394x+0.0827 R2=0.9995 mAT/tab.=10m'=21.00 
40 2.062 y=0.0398x+0.0821 R2=0.9996 mAT/tab.=20m'=41.24 
Turbovas 10 2.004 y=0.0395x+0.0792 R2=0.9994 mAT/tab.=5m'=10.02 
20 2.036 y=0.0399x+0.0812 R2=0.9995 mAT/tab.=10m'=20.36 
*y= n A, x= concentration of Rosuvastatin (µg/ml)= m' = intercept/slope. 
 
Table 5: Determination of RSV in some Syrian pharmaceutical preparations using spectrophotometric method through complex 
formation with BCG in chloroform, λmax=416 nm 




Recovery % x , (Recovery %) 
RP-HPLC [42] 
Rosuvastatin 5 4.90 3.8 98.0 98.4 
10 10.08 3.7 100.8 100.6 
20 20.64 3.6 103.2 103.4 
40 40.40 3.6 101.0 100.8 
Rosuvastatin- 
Elsaad 
5 4.80 3.9 96.0 96.5 
10 9.97 3.7 99.7 99.8 
20 21.00 3.6 105.0 104.7 
40 41.24 3.5 103.1 103.0 
Turbovas 10 10.02 3.7 100.2 100.5 




Some drugs as ASP, FEN, EZE, CP, TEL, GLM and DIL exist in 
combined with rosuvastatin in some pharmaceutical formulations. 
ASP, FEN and tablet fillers (excipients) such as lactose, starch, stearic 
acid, preservations and bacteriostatics while used in parental 
preparations don’t interfere in this method. EZE, CP, TEL, GLM and 
DIL, interfere.  
CONCLUSION 
The developed spectrophotometric method is simple, direct 
(extraction-free), cost-effective and specific for the determination 
of rosuvastatin in pure and its pharmaceutical formulations.  
This method is based on the formation of ion-pair complex between 
rosuvastatin and bromocresol green in chloroform (λmax =416 nm). 
Beer’s law in the optimum experimental conditions is valid within 
a concentration range of 0.482-24.077 μg/ml. The developed 
method is applied for the determination of rosuvastatin in pure 
and its commercial tablets without any interference from 
excipients, aspirine and fenofibrate with an average recovery of 
96.0 to 105.0%.  
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